Paola Montenegro

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort

Güney Bademci, Joseph Foster, Nejat Mahdieh et al. · Genetics in Medicine · 2015 · 159 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Alpha-Synuclein Is a Target of Fic-Mediated Adenylylation/AMPylation: Possible Implications for Parkinson's Disease

Anwesha Sanyal, Sayan Deb Dutta, Ali Camara et al. · Journal of Molecular Biology · 2019 · 46 citations · Full text

Life Sciences, Biochemistry, Neuroscience +13

Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons

Angela Cruz‐Hernandez, Zeynep Sena Ağım, Paola Montenegro et al. · NeuroToxicology · 2018 · 30 citations · Full text

Medicine, Neurobiology, Neuroscience +16

Novel domain-specific POU3F4 mutations are associated with X-linked deafness: examples from different populations

Güney Bademci, Akeem O. Lasisi, Kemal O. Yariz et al. · BMC Medical Genetics · 2015 · 27 citations · Full text

Life Sciences, Audiology, Genetics +12